(Q40081527)

17 September 2017

Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression (English)

1 reference

17 September 2017

1 reference

1 reference

Robinson M

1

1 reference

17 September 2017

Ge Y

2

1 reference

17 September 2017

Ko D

3

1 reference

17 September 2017

Yendluri S

4

1 reference

17 September 2017

Laflamme G

5

1 reference

17 September 2017

Hawkins L

6

1 reference

17 September 2017

Jooss K

7

1 reference

17 September 2017

14 September 2007

1 reference

17 September 2017

1 reference

17 September 2017

15

1 reference

17 September 2017

9-17

1 reference

17 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701093

17 September 2017

0 references

cites work

Development of transcriptionally regulated oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Replication-selective viruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Recent progress in the battle between oncolytic viruses and tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Tumor-specific intravenous gene delivery using oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Identification of novel insertion sites in the Ad5 genome that utilize the Ad splicing machinery for therapeutic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Development of a transposon-based approach for identifying novel transgene insertion sites within the replicating adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Generation of adenovirus by transfection of plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Adenovirus promoters and E1A transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Development of novel E1-complementary cells for adenoviral production free of replication-competent adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

Multigene expression from a replicating adenovirus using native viral promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

7 January 2021

Infection of Mouse Liver by Human Adenovirus Type 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

7 January 2021

Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

7 January 2021

Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

7 January 2021

Transcripts from the adenovirus-2 major late promoter yield a single early family of 3' coterminal mRNAs and five late families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701093

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701093

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference